Melanocortin-4 receptor binding compounds and methods of use thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20080269217A1
SERIAL NO

12149440

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided are MC4-R binding compounds of the formula XVII: wherein L.sub.2 is a linker group, and P.sup.1, P.sup.2, P.sup.3, P.sup.4, Z.sup.1, Z.sup.2, Z.sup.3, Z.sup.4, Z.sup.5, t, s, and R are as described in the specification. Methods of using the compounds to treat MC4-R associated disorders, such as disorders associated with weight loss, are also provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ORE PHARMACEUTICALS INCCAMBRIDGE MA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Claiborne, Christopher F Cambridge, MA 44 574
Dai, Mingshi Billerica, MA 7 118
Maguire, Martin P Woburn, MA 59 2382
Marsilje, Thoma H San Diego, CA 1 5
Patane, Michael Andover, MA 39 162
Solomon, Michael E Nashua, MA 9 58
Vos, Tricia J Medford, MA 34 380

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation